针对英利昔单抗的副作用和相关并发症进行了阐述。
Infliximab and its side-effect profile are discussed, along with other associated complications.
英利昔单抗和依那西普分别使用与患淋巴瘤风险间也无相关关系。
Infliximab and etanercept considered individually also were not associated with a risk of lymphoma.
目的:评价英利昔单抗在消化系统相关疾病治疗中的疗效和安全性。
OBJECTIVE: To evaluate the efficacy and the safety of infliximab for the treatment of the diseases of digestive system.
应用推荐